These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 31366458)

  • 21. Prevalence and treatment of central sleep apnoea emerging after initiation of continuous positive airway pressure in patients with obstructive sleep apnoea without evidence of heart failure.
    Westhoff M; Arzt M; Litterst P
    Sleep Breath; 2012 Mar; 16(1):71-8. PubMed ID: 21347650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome.
    Drager LF; Togeiro SM; Polotsky VY; Lorenzi-Filho G
    J Am Coll Cardiol; 2013 Aug; 62(7):569-76. PubMed ID: 23770180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimal treatment of obstructive sleep apnea and excessive sleepiness.
    Rosenberg R; Doghramji P
    Adv Ther; 2009 Mar; 26(3):295-312. PubMed ID: 19337706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of obstructive sleep apnea in patients with acute coronary syndrome in relation to diabetes status.
    Wang X; Fan J; Du Y; Ma C; Ma X; Nie S; Wei Y
    BMJ Open Diabetes Res Care; 2019; 7(1):e000737. PubMed ID: 31908793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of moderate-to-severe obstructive sleep apnea on the clinical manifestations of plaque vulnerability and the progression of coronary atherosclerosis in patients with acute coronary syndrome.
    Nakashima H; Kurobe M; Minami K; Furudono S; Uchida Y; Amenomori K; Nunohiro T; Takeshita S; Maemura K
    Eur Heart J Acute Cardiovasc Care; 2015 Feb; 4(1):75-84. PubMed ID: 24855286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Continuous Positive Airway Pressure on Lipidaemia and High-sensitivity C-reactive Protein Levels in Non-obese Patients with Coronary Artery Disease and Obstructive Sleep Apnoea.
    Huang Z; Liu Z; Zhao Z; Zhao Q; Luo Q; Tang Y
    Heart Lung Circ; 2016 Jun; 25(6):576-83. PubMed ID: 26804247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic impact of residual SYNTAX score in patients with obstructive sleep apnea and acute coronary syndrome: a prospective cohort study.
    Zeng Y; Yang S; Wang X; Fan J; Nie S; Wei Y
    Respir Res; 2019 Feb; 20(1):43. PubMed ID: 30819182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A clinical approach to obstructive sleep apnea as a risk factor for cardiovascular disease.
    Maeder MT; Schoch OD; Rickli H
    Vasc Health Risk Manag; 2016; 12():85-103. PubMed ID: 27051291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Ethnicity on the Prevalence of Obstructive Sleep Apnoea in Patients with Acute Coronary Syndrome: A Pooled Analysis of the ISAACC Trial and Sleep and Stent Study.
    Koo CY; de la Torre AS; Loo G; Torre MS; Zhang J; Duran-Cantolla J; Li R; Mayos M; Sethi R; Abad J; Furlan SF; Coloma R; Hein T; Ho HH; Jim MH; Ong TH; Tai BC; Turino C; Drager LF; Lee CH; Barbe F
    Heart Lung Circ; 2017 May; 26(5):486-494. PubMed ID: 27939743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Personalised medicine in sleep respiratory disorders: focus on obstructive sleep apnoea diagnosis and treatment.
    Bonsignore MR; Suarez Giron MC; Marrone O; Castrogiovanni A; Montserrat JM
    Eur Respir Rev; 2017 Dec; 26(146):. PubMed ID: 29070581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of long-term adherence to continuous positive airway pressure in patients with obstructive sleep apnea and cardiovascular disease.
    Van Ryswyk E; Anderson CS; Antic NA; Barbe F; Bittencourt L; Freed R; Heeley E; Liu Z; Loffler KA; Lorenzi-Filho G; Luo Y; Margalef MJM; McEvoy RD; Mediano O; Mukherjee S; Ou Q; Woodman R; Zhang X; Chai-Coetzer CL
    Sleep; 2019 Oct; 42(10):. PubMed ID: 31587046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of continuous positive airway pressure and isocapnic-hypoxia on cerebral autoregulation in patients with obstructive sleep apnoea.
    Waltz X; Beaudin AE; Hanly PJ; Mitsis GD; Poulin MJ
    J Physiol; 2016 Dec; 594(23):7089-7104. PubMed ID: 27644162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuous positive airway pressure improves sleep and daytime sleepiness in patients with Parkinson disease and sleep apnea.
    Neikrug AB; Liu L; Avanzino JA; Maglione JE; Natarajan L; Bradley L; Maugeri A; Corey-Bloom J; Palmer BW; Loredo JS; Ancoli-Israel S
    Sleep; 2014 Jan; 37(1):177-85. PubMed ID: 24470706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Positive Airway Pressure on Cardiovascular Outcomes in Coronary Artery Disease Patients with Nonsleepy Obstructive Sleep Apnea. The RICCADSA Randomized Controlled Trial.
    Peker Y; Glantz H; Eulenburg C; Wegscheider K; Herlitz J; Thunström E
    Am J Respir Crit Care Med; 2016 Sep; 194(5):613-20. PubMed ID: 26914592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of continuous positive airway pressure on long-term cardiovascular outcomes in patients with coronary artery disease and obstructive sleep apnea: a systematic review and meta-analysis.
    Wang X; Zhang Y; Dong Z; Fan J; Nie S; Wei Y
    Respir Res; 2018 Apr; 19(1):61. PubMed ID: 29636058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BPAP is an effective second-line therapy for obese patients with OSA failing regular CPAP: A prospective observational cohort study.
    Ishak A; Ramsay M; Hart N; Steier J
    Respirology; 2020 Apr; 25(4):443-448. PubMed ID: 31407464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of CPAP to reduce arterial stiffness in moderate-to-severe obstructive sleep apnoea, without excessive daytime sleepiness (STIFFSLEEP): an observational cohort study protocol.
    Mineiro MA; Marques da Silva P; Alves M; Virella D; Marques Gomes MJ; Cardoso J
    BMJ Open; 2016 Jul; 6(7):e011385. PubMed ID: 27406645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Continuous positive airway pressure delivery interfaces for obstructive sleep apnoea.
    Chai CL; Pathinathan A; Smith B
    Cochrane Database Syst Rev; 2006 Oct; 2006(4):CD005308. PubMed ID: 17054251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of long-term adherence to continuous positive airway pressure in patients with obstructive sleep apnoea and acute coronary syndrome.
    Florés M; Martinez-Alonso M; Sánchezde-la-Torre A; Aldomà A; Galera E; Barbé F; Sánchezde-la-Torre M; Dalmases M
    J Thorac Dis; 2018 Jan; 10(Suppl 1):S124-S134. PubMed ID: 29445536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of obstructive sleep apnoea in REM behaviour disorder: response to continuous positive airway pressure therapy.
    Gabryelska A; Roguski A; Simpson G; Maschauer EL; Morrison I; Riha RL
    Sleep Breath; 2018 Sep; 22(3):825-830. PubMed ID: 28951996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.